semaglutide and inflammation does more than reduce appetite—it works across several organs that influence metabolic health. Clinical studies show that semaglutide can: 🧠 Improve appetite regulation through brain pathways 🩸 Reduce within the Frontiers | Anti-inflammatory effect of

the two large null dementia-prevention trials ( GEM , JAMA 2008 and GuidAge , Lancet Neurology 2012)

Liposomal Glutathione delivers 100 mg of active glutathione per 1 mL serving, carried in tiny fat-based spheres called liposomes made from sunflower lecithin to help protect and absorb it.* This is the form your body can put to work right away for normal antioxidant defense and natural detox support.* You may notice support for immune resilience and overall well-being as you maintain healthy glutathione status.* Glutathione status naturally declines with age and can be lowered by stress and environmental factors.* Results will vary based on your current health, lifestyle, and guidance from your healthcare practitioner.* Liposomal Glutathione is designed for daily use when taken as directed.* Consult your healthcare practitioner before use if you are pregnant, breastfeeding, planning to become pregnant, taking medications, or managing a health condition.* Liposomal Glutathione is a liquid designed for fast absorption, while S-Acetyl Glutathione Synergy is a capsule formula that pairs glutathione with key supporting nutrients to help support your body in using and producing more glutathione.* Ask your healthcare practitioner which option is the right fit for your needs.* Liposomal Glutathione Liposomal Reduced Glutathione (100 mg per Serving) with Phospholipid Delivery for Antioxidant Status, Immune Function, Liver Detoxification, and Heavy Metal Clearance* Key Performance Benefits* Supports healthy glutathione status Promotes antioxidant status Supports immune function Supports normal liver detoxification pathways, including normal heavy metal clearance What This Product Is Liposomal Glutathione provides 100 mg of glutathione in its beneficial reduced form per 1 mL serving (approximately 2 pumps), formulated with liposomal technology for optimal absorption and utilization

Marso, S.P., et al

Quick Answer: Current evidence does not establish that GLP-1 receptor agonists cause colon cancer in humans